Children and adolescents with cancer may have pre-existing psychiatric diagnoses, and are also vulnerable to developing mood or anxiety problems in the context of the psychological and medical challenges of treatment. When behavioural interventions are not enough, effective psychotropic medication may also be used to treat depression and anxiety. These medications can be used safely in children receiving oncology treatment, although robust studies are lacking.
This presentation described an approach to assessment and treatment for depression and anxiety in youth undergoing treatment for cancer.
Anna C. Muriel, MD, MPH
Chief, Division of Pediatirc Psychosocial Oncology,
Department of Psychosocial Oncology and Palliative Care
Dana Farber Cancer Institute, Boston MA